Antithrombotic Activity of an Indolinone Derivative – a Soluble Guanylate Cyclase Stimulator
Authors:
Open Access
- 30 August 2022
- journal article
- Published by Center of Pharmaceutical Analytics Ltd in Drug development & registration
- Vol. 11 (3) , 70-74
Abstract
Антитромботическая активность производного индолинона – стимулятора растворимой гуанилатциклазыKeywords
This publication has 10 references indexed in Scilit:
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonaryembolism developed in collaboration with the European Respiratory Society (ERS)Russian Journal of Cardiology, 2020
- Complexity of Antiplatelet Therapy in Coronary Artery Disease PatientsAmerican Journal of Cardiovascular Drugs, 2020
- Антиагрегантная активность нового производного индолинонаЭкспериментальная и клиническая фармакология, 2019
- Protective effects of gelsolin in acute pulmonary thromboembolism and thrombosis in the carotid artery of micePLOS ONE, 2019
- Selection of appropriate statistical methods for data analysisAnnals of Cardiac Anaesthesia, 2019
- Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in RatsFrontiers in Pharmacology, 2018
- Discovery and development of next generation sGC stimulators with diverse multidimensional pharmacology and broad therapeutic potentialNitric Oxide, 2018
- Refinement of Mouse Protocols for the Study of Platelet Thromboembolic Responses In VivoThrombosis and Haemostasis, 2017
- Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E–Deficient MiceTH Open, 2017
- Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesisThrombosis and Haemostasis, 2007